Skip to main content
. Author manuscript; available in PMC: 2023 Feb 4.
Published in final edited form as: N Engl J Med. 2022 Aug 4;387(5):397–407. doi: 10.1056/NEJMoa2203067

Figure 5. Parasitemia after Controlled Human Malaria Infection.

Figure 5.

A Kaplan–Meier analysis shows the time to blood-stage parasitemia as measured by polymerase-chain-reaction analysis. Participants were monitored daily starting on day 7 after controlled human malaria infection through day 17, with a final test performed on day 21. A primary efficacy analysis performed with the use of a two-sided Barnard test comparing parasitemia among the participants who received L9LS with that among the control participants yielded a P value of less than 0.001.